You Searched For "gilead science" and got 20 results
Sort By:
Batches of the COVID-19 treatment drug Remdesivir were recalled after glass particles were found in some vials
Biopharmaceutical company Gilead Sciences announced that two lots of Remdesivir are being recalled …
Cheryl Teh
Gilead rises after pricing its coronavirus-fighting drug remdesivir
"We believe that pricing remdesivir well below value is the right and responsible thing to do," sai…
Carmen Reinicke
FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients
Following an evaluation of the emergency use authorization criteria and scientific evidence a…
PTI
Gilead slides 4% after COVID-19 drug shows limited benefit in moderately ill patients
Patients who received remdesivir for five days were 65% more likely to show signs of recovery than …
Saloni Sardana
Gilead surges 17% on report that drug shows effectiveness against COVID-19
In a Chicago hospital, all patients with Covid-19 treated with Gilead's Remdesivir were discharged …
Carmen Reinicke
Immunomedics soars 106% after Gilead agrees to acquire the cancer-drug company for $21 billion
Gilead expects the deal to immediately bolster its revenue growth, and to be neutral to accretive t…
Matthew Fox
The federal government finally announced initial plans to distribute Gilead's coronavirus drug remdesivir after days of confusion
The government said it's distributing the promising coronavirus drug, remdesivir, to some hard-hit …
Anna Medaris Miller
Regeneron widens its lead as the S&P 500's top performer after saying key COVID-19 drug may be available in the fall
Regeneron's antibody cocktail COVID-19 treatment is set to begin clinical trials over the summer, w…
Carmen Reinicke
What it'll take to get a vaccine to Americans
These are the top stories written by Business Insider's healthcare team for the week ending October…
Lydia Ramsey Pflanzer
Gilead's remdesivir just got the first FDA approval to be used as a treatment for coronavirus patients
Gilead Sciences just received approval from the US Food and Drug Administration to use its antivira…
Allana Akhtar
See the pitch deck a healthcare startup founded by 2 ex-Googlers used to raise $47 million
These are Business Insider's biggest healthcare stories for October 19.
Lydia Ramsey Pflanzer
Dow surges 500 points on optimism around US economic reopening plan
Positive results reported from Gilead's coronavirus treatment trials offered new optimism around an…
Ben Winck
Trump's doctors are targeting a 'sweet spot' in fighting COVID-19 by using experimental treatments early, but physicians caution the data is limited
"We are clearly in a data-free zone right here," an infectious-disease physician told Business Insi…
Andrew Dunn
The US bought up 90% of the world's supply of remdesivir for the next 3 months, and patents mean many countries won't be able to get any
Gilead Sciences will sell almost all of the world's supply of remdesivir to the US for the next thr…
Mia Jankowicz
The $96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients
If the inhaled version of remdesivir works, it "could have significant implications in helping to s…
Andrew Dunn
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
The nonprofit group often finds drugs to be overpriced. For the first potential COVID-19 drug, it s…
Andrew Dunn
Dispensed: A week of drug developments, the plan to restart hospitals, and some non-coronavirus news
Welcome to Dispensed, BI's weekly healthcare newsletter. This week, the TLDR on remdesivir, a promi…
Lydia Ramsey
Scientists are racing to discover ways to treat and prevent coronavirus. Here's the difference between a treatment and a vaccine.
Vaccines prepare the body's immune system to fight off invaders, while treatments are there to help…
Lydia Ramsey
Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug
One of the most promising coronavirus treatment candidates succeeded in a late-stage trial in COVID…
Andrew Dunn
Remdesivir linked to reduced risk of death in severe Covid-19 patients
This is an important finding that requires confirmation in prospective clinical trials, Gilead s…